Connie Jimenez receives Juan Pablo Albar Proteome Pioneer Award

• Post by: OPL
• June 26, 2025
• Comments off

At the annual conference of the European Proteomics Association (EuPA) in Saint-Malo, Connie Jimenez received the Juan Pablo Albar Proteome Pioneer Award, in a majority vote by the national proteomics societies of Europe. The award is given to individuals with a leading and long-standing commitment to sharing resources for the development of excellent research in the proteomics field.

During her award lecture, Connie presented highlights of 33 years of application of mass spectrometry in the biological and biomedical sciences. In the 1990s, she pioneered single cell analysis by mass spectrometry to study neuropeptide profiles, in a time that the field was mainly analyzing synthetic peptides and proteins. With her own lab, she pioneered label-free proteomics for the large-scale study of clinical samples, discovering protein biomarkers for colorectal cancer screening, creating a large pan-cancer landscape (http://r2platform.com/TPCPA) and developing a pipeline for ranked kinase activity analysis in individual tumors (www.inkascore.org) as predictive markers for therapy selection.

Connie is a real team-player. As a founding member of the Netherlands Proteomics Platform, she fosters networking among proteome scientists in The Netherlands and as elected Vice-President of EuPA, she strives to do the same at the European level. She feels very afortunate to be part of the national and international proteomics families and looks forward to many more exciting years in which she hopes to drive mass spectrometry into real clinical applications.